Accrol Group Analyst Q&A “Valuation is cheap at the moment given the growth opportunities ahead” (LON:ACRL) 15 April 2021
Sativa Wellness Group Q&A: Increasing range of services will have a positive impact on revenues (AQSE:SWEL) 13 April 2021
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Babcock International Positioned for Growth with Strong Financials and Market Focus – Shore Capital 6 November 2024
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Accrol Group Analyst Q&A “Valuation is cheap at the moment given the growth opportunities ahead” (LON:ACRL) 15 April 2021
Sativa Wellness Group Q&A: Increasing range of services will have a positive impact on revenues (AQSE:SWEL) 13 April 2021
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Babcock International Positioned for Growth with Strong Financials and Market Focus – Shore Capital 6 November 2024
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
iRhythm Technologies (IRTC) Stock Analysis: A 30.66% Upside Beckons in the Rapidly Growing Medical Device Sector 15 December 2025
Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Its 434% Revenue Growth and Strategic Position in RNA Therapeutics 15 December 2025
BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 13.33% Potential Upside in the Biotech Space 15 December 2025
Moderna, Inc. (MRNA) Stock Analysis: Exploring the 20% Upside Amidst Biotech Challenges 15 December 2025
Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential and Investment Viability 15 December 2025
Integer Holdings Corporation (ITGR) Stock Analysis: Examining the 17.48% Upside Potential 15 December 2025
Corcept Therapeutics (CORT) Stock Analysis: Exploring a 53.71% Potential Upside in the Biotech Sector 15 December 2025
Akero Therapeutics, Inc. (AKRO) Investor Outlook: Evaluating a Promising Biotech with a 3.39% Upside Potential 15 December 2025
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Opportunities with a 12% Potential Upside 15 December 2025
Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 25.58% Potential Upside in the Biotech Sector 15 December 2025
TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring the 14% Upside Potential in the Revolutionary Organ Transplant Market 15 December 2025
West Pharmaceutical Services, Inc. (WST) Stock Analysis: Capturing a 29% Upside in the Healthcare Sector 15 December 2025
Exelixis, Inc. (EXEL) Stock Analysis: Unveiling a 9.94% Potential Upside in the Biotech Marvel 15 December 2025
Tenet Healthcare Corporation (THC) Stock Analysis: Exploring an 18.62% Potential Upside 15 December 2025
Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a 106.74% Upside Potential in Biotech Innovation 15 December 2025
Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 23.20% Revenue Growth 15 December 2025
Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 27% Upside Potential Beckons Investors 15 December 2025
International Consolidated Airlns Grp SA 35.4% potential upside indicated by RBC Capital Markets 21 June 2024
Accrol Group Analyst Q&A “Valuation is cheap at the moment given the growth opportunities ahead” (LON:ACRL) 15 April 2021
Sativa Wellness Group Q&A: Increasing range of services will have a positive impact on revenues (AQSE:SWEL) 13 April 2021
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
